EMA Greenlights Self-Administered Acromegaly Drug

The drug works by reducing and normalizing IGF-1 and growth hormone levels.
Medscape Medical News

source https://www.medscape.com/viewarticle/ema-greenlights-self-administered-acromegaly-drug-2025a1000ae4?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

New AAFP practice guideline sets blood pressure targets for adults with hypertension

Heart Failure Care Outside of ICU Can Lower Cost